Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.

Hair loss after COVID-19 is common, starts sooner in severe cases, and often comes with scalp pain.

Telogen effluvium is a common, often temporary hair loss caused by stress and other factors, and it's hard to pinpoint and treat.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

A man's unusual scalp folds caused by a skin condition were treated with surgery and remained unchanged two years later.

The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.

Maintaining anticoagulation is crucial for patients with antiphospholipid syndrome.

A man's sudden hair loss and color change to white was diagnosed as alopecia areata and it improved on its own after six months.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

The document concludes that early diagnosis and treatment are crucial for children with hair loss to prevent permanent damage, although not all conditions can be effectively treated.

Lichen planopilaris is the most common type of scarring hair loss observed, with a variety of symptoms and tissue changes.

A woman's hair loss was treated successfully with iron supplements for her iron deficiency.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

High levels of the seizure medication sodium valproate can cause hair loss.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Use trichoscopy to diagnose hair loss; treat with minoxidil, finasteride, or dutasteride; consider platelet-rich plasma and spironolactone.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Low ferritin and cobalamin levels are better indicators of chronic hair loss in reproductive-age women than hemoglobin levels.

Low Vitamin D levels are linked to female hair loss.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Careful management of blood thinners is crucial for lupus patients with APS.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

A patient with a scalp condition and benign skin tumor experienced hair loss and did not improve with treatment, choosing not to have surgery despite a small cancer risk.

Oral and topical finasteride are effective and safe for treating female hair loss.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

The health of the sentinel lymph node is the best indicator of survival for patients with thick skin cancer.

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.